CORRECTING and REPLACING Verici Dx Announces Publication Validating Pre-Transplant Gene Signature Test for Predicting Early Acute Rejection in Kidney Transplant Recipients

FRANKLIN, Tenn.--(BUSINESS WIRE)--In the first and last paragraphs, the text should read: Pre-Transplant Risk Assessment (instead of: Pre-Transplant Rejection Assessment). The updated release reads: VERICI DX ANNOUNCES PUBLICATION VALIDATING PRE-TRANSPLANT GENE SIGNATURE TEST FOR PREDICTING EARLY ACUTE REJECTION IN KIDNEY TRANSPLANT RECIPIENTS Test outperformed conventional risk metrics in predicting early acute rejection in the first two months following deceased donor kidney transplant Enable.